Product and product-related services revenue increased by 119% and 89%, respectively, compared to the three and six-month periods in the prior year Call scheduled for today, August 6 , at 4:30pm ET TUCSON, Ariz. , Aug. 06, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Ariz. , July 25, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the Canaccord Genuity 39 th…
TUCSON, Ariz. , July 24, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2019 after the market close on…
TUCSON, Ariz. , July 08, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the release of its HTG EdgeSeq TM Reveal data analytics software, version 1.2.0….
TUCSON, Ariz. , July 01, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it presented its technology in an oral presentation at the annual WIN Symposium meeting for personalized…
TUCSON, Ariz. , May 24, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that on May 22, 2019 the Compensation Committee of its Board of Directors granted inducement stock options to…
Call scheduled for today, May 9, at 4:30pm ET TUCSON, Ariz. , May 09, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2019…
TUCSON, Ariz. , April 30, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2019 after the market close on…
Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. , April 30, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its…
TUCSON, Ariz. , March 27, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and…
Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz. , March 07, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission…
Page last updated March 20, 2023